Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,011 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.
Lee JE, Yu SH, Kim SR, Ahn KJ, Song KH, Lee IK, Shon HS, Kim IJ, Lim S, Kim DM, Chung CH, Lee WY, Lee SH, Kim DJ, Cho SR, Jung CH, Jeon HJ, Lee SH, Park KY, Rhee SY, Kim SG, Park SO, Kim DJ, Kim BJ, Lee SA, Kim YH, Kim KS, Seo JA, Nam-Goong IS, Lee CW, Kim DK, Kim SW, Cho CG, Kim JH, Kim YJ, Yoo JM, Min KW, Lee MK. Lee JE, et al. Among authors: kim sr, kim yh, kim ij, kim yj, kim sg, kim sw, kim dj, kim dk, kim bj, kim ks, kim dm, kim jh. Diabetes Metab J. 2024 Jul;48(4):730-739. doi: 10.4093/dmj.2023.0077. Epub 2024 May 20. Diabetes Metab J. 2024. PMID: 38763510 Free PMC article. Clinical Trial.
Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise.
Park J, Park SW, Yoon KH, Kim SR, Ahn KJ, Lee JH, Mok JO, Chung CH, Han KA, Koh GP, Kang JG, Lee CB, Kim SH, Kwon NY, Kim DM. Park J, et al. Among authors: kim sr, kim sh, kim dm. Diabetes Obes Metab. 2017 Dec;19(12):1681-1687. doi: 10.1111/dom.12987. Epub 2017 Jul 7. Diabetes Obes Metab. 2017. PMID: 28448688 Free PMC article. Clinical Trial.
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Oh TJ, Yu JM, Min KW, Son HS, Lee MK, Yoon KH, Song YD, Park JY, Jeong IK, Cha BS, Kim YS, Baik SH, Kim IJ, Kim DM, Kim SR, Lee KW, Park JH, Lee IK, Park TS, Choi SH, Park SW. Oh TJ, et al. Among authors: kim sr, kim ij, kim dm, kim ys. Diabetes Metab J. 2019 Jun;43(3):276-286. doi: 10.4093/dmj.2018.0051. Epub 2018 Dec 7. Diabetes Metab J. 2019. PMID: 30604594 Free PMC article. Clinical Trial.
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.
Kim SG, Kim KJ, Yoon KH, Chun SW, Park KS, Choi KM, Lim S, Mok JO, Lee HW, Seo JA, Cha BS, Kim MK, Shon HS, Choi DS, Kim DM. Kim SG, et al. Among authors: kim kj, kim dm, kim mk. Diabetes Obes Metab. 2020 Oct;22(10):1869-1873. doi: 10.1111/dom.14085. Epub 2020 Jun 18. Diabetes Obes Metab. 2020. PMID: 32406573 Clinical Trial.
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial.
Lee YH, Kim DM, Yu JM, Choi KM, Kim SG, Park KS, Son HS, Chung CH, Ahn KJ, Lee SH, Song KH, Kwon SK, Park HK, Won KC, Jang HC; ACACIA Study Group. Lee YH, et al. Among authors: kim sg, kim dm. Diabetes Obes Metab. 2023 May;25(5):1174-1185. doi: 10.1111/dom.14959. Epub 2023 Jan 10. Diabetes Obes Metab. 2023. PMID: 36564983 Clinical Trial.
Prevalence of chronic complications in korean patients with type 2 diabetes mellitus based on the korean national diabetes program.
Rhee SY, Chon S, Kwon MK, Park IeB, Ahn KJ, Kim IJ, Kim SH, Lee HW, Koh KS, Kim DM, Baik SH, Lee KW, Nam MS, Park YS, Woo JT, Kim YS. Rhee SY, et al. Among authors: kim ij, kim sh, kim dm, kim ys. Diabetes Metab J. 2011 Oct;35(5):504-12. doi: 10.4093/dmj.2011.35.5.504. Epub 2011 Oct 31. Diabetes Metab J. 2011. PMID: 22111042 Free PMC article.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.
Rhee EJ, Lee WY, Min KW, Shivane VK, Sosale AR, Jang HC, Chung CH, Nam-Goong IS, Kim JA, Kim SW; Gemigliptin Study 006 Group. Rhee EJ, et al. Diabetes Obes Metab. 2013 Jun;15(6):523-30. doi: 10.1111/dom.12060. Epub 2013 Jan 30. Diabetes Obes Metab. 2013. PMID: 23320436 Clinical Trial.
Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: a multicenter, randomized, double-blind, parallel-group, placebo controlled trial.
Kim SG, Kim DM, Woo JT, Jang HC, Chung CH, Ko KS, Park JH, Park YS, Kim SJ, Choi DS. Kim SG, et al. Among authors: kim sj, kim dm. PLoS One. 2014 Apr 15;9(4):e92843. doi: 10.1371/journal.pone.0092843. eCollection 2014. PLoS One. 2014. PMID: 24736628 Free PMC article. Clinical Trial.
Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
Kim HS, Kim DM, Cha BS, Park TS, Kim KA, Kim DL, Chung CH, Park JH, Jang HC, Choi DS. Kim HS, et al. Among authors: kim ka, kim dl, kim dm. J Diabetes Investig. 2014 Nov;5(6):701-8. doi: 10.1111/jdi.12201. Epub 2014 Mar 16. J Diabetes Investig. 2014. PMID: 25422771 Free PMC article.
1,011 results